LR124

Interim study to examine the role of a pharmacy benefit manager within the Nebraska health insurance industry and the impact on prescription drug prices

Introduced·4/16/25
Introduced Text

Interim study to examine pharmacy benefit manager practices and their impact on prescription drug prices in Nebraska.

This bill proposes an interim study to investigate the role of pharmacy benefit managers (PBM) in Nebraska's health insurance industry and their effect on prescription drug prices. The study will evaluate PBM practices, including contractual relationships, reimbursement models, and formulary management. It will also assess transparency, accountability, and the impact on patient access and independent pharmacies. The Banking, Commerce and Insurance Committee will conduct the study and report findings to the Legislative Council or Legislature.

Included in complete analysis

  • Overview
  • Core Provisions
  • Implementation
  • Impact
  • Legal Framework
  • Critical Issues

See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.

Where it stands

Current
Banking, Commerce and Insurance Committee
Next
Committee decision

Sponsors

N
1
0
Democratic CaucusRepublican Caucus

History

May 19, 2025

Legislature

Referred to Banking, Commerce and Insurance Committee

Apr 16, 2025

Legislature

Date of introduction

Apr 16, 2025

Legislature

Referred to Executive Board